Earnings results for Acutus Medical (NASDAQ:AFIB)
Acutus Medical, Inc. is expected* to report earnings on 09/17/2020 after market close. The report will be for the fiscal Quarter ending Jun 2020. According to Zacks Investment Research, based on 2 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.83.
Analyst Opinion on Acutus Medical (NASDAQ:AFIB)
6 Wall Street analysts have issued ratings and price targets for Acutus Medical in the last 12 months. Their average twelve-month price target is $38.75, predicting that the stock has a possible upside of 9.28%. The high price target for AFIB is $40.00 and the low price target for AFIB is $38.00. There are currently 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of “Buy.”
Acutus Medical has received a consensus rating of Buy. The company’s average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings. According to analysts’ consensus price target of $38.75, Acutus Medical has a forecasted upside of 9.3% from its current price of $35.46. Acutus Medical has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.
Dividend Strength: Acutus Medical (NASDAQ:AFIB)
Acutus Medical does not currently pay a dividend. Acutus Medical does not have a long track record of dividend growth.
Insiders buying/selling: Acutus Medical (NASDAQ:AFIB)
In the past three months, Acutus Medical insiders have not sold or bought any company stock.
Earnings and Valuation of Acutus Medical (NASDAQ:AFIB
Earnings for Acutus Medical are expected to grow in the coming year, from ($3.67) to ($2.47) per share.
More latest stories: here